ACM
ATYR

ADAR1 Capital Management’s aTyr Pharma ATYR Stock Holding History

ADAR1 Capital Management’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.2K Hold
50,685
– – ﹤0.01% 273
2026
Q1 		$39.5K Hold
50,685
– – ﹤0.01% 303
2025
Q4 		$39.7K Sell
50,685
-124,315
-71% -$102K ﹤0.01% 266
2025
Q3 		$126K Buy
+175,000
New +$793K 0.01% 197

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ADAR1 Capital Management's ATYR Position: Q2 2026 in Review

ADAR1 Capital Management held its aTyr Pharma (ATYR) position steady in Q2 2026 at 50,685 shares worth $30.2K. The position accounts for ﹤0.01% of the portfolio, ranked #273.

ADAR1 Capital Management first reported a position in ATYR in Q3 2025 and has held it in 4 quarters since. The position peaked at $126K in Q3 2025. 90 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • ADAR1 Capital Management held 50,685 shares of aTyr Pharma worth $30.2K as of Q2 2026.
  • ADAR1 Capital Management left its aTyr Pharma share count unchanged in Q2 2026.
  • aTyr Pharma made up ﹤0.01% of ADAR1 Capital Management's portfolio in Q2 2026, its #273 holding.
  • ADAR1 Capital Management first reported a position in aTyr Pharma in Q3 2025 and has held it in 4 quarters since.
  • ADAR1 Capital Management's aTyr Pharma position peaked at $126K in Q3 2025.
  • 90 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.